<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02868749</url>
  </required_header>
  <id_info>
    <org_study_id>BVL/JVL</org_study_id>
    <nct_id>NCT02868749</nct_id>
  </id_info>
  <brief_title>Histology and Ultrasound Pilot Study of HA Gels Adipose Tissue</brief_title>
  <official_title>Comparative Clinical, Histological and Ultrasound Pilot Study of Two Hyaluronic Acid Gel Fillers, Designed for Deep Injection, in Adipose Tissue</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vandeputte, Joan, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vandeputte, Joan, M.D.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a single-blind intra-individual comparative study to evaluate the short and
      medium term tissue response after the injection of 2 brands of hyaluronic acid gels (HA),
      designed for deep injection, that have been used for several years on a worldwide scale.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be disclosed to patients who present with an indication for either
      abdominoplasty or bilateral breast reduction with a Wise pattern skin excision (inverted T
      inframammary scar) Informed consent will be obtained from volunteers at their next
      consultation, during which the preoperative preparation is finalised and the surgery is
      booked.

      Participants will receive injections for the first time three weeks to four months before the
      operation and for the second time five to nine days before the operation, in tissue that will
      be removed during the surgery.

      In each session, through one single access point, a linear retrograde, subcutaneous injection
      will be performed with 0,5 ml of each of the studied hyaluronic acid gels, each in an
      opposite direction, each parallel to the skin surface.

      Both sessions will be monitored by ultrasound examination. After the injections, the 2 cm of
      injected area which is most remote from the entrance point of the cannula will be remodelled
      by finger pressure and tissue pinching, to simulate remodelling as commonly performed after
      filler injection.

      At the beginning of the operation, the injected subcutaneous fat will be removed with the
      overlying skin, to be sent for histologic examination.

      The objective of the histologic examination is to assess the tissue response at one week
      versus three weeks to four months after the injection, as well as to assess the spread of the
      products, with and without remodelling after injection.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 22, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2018</completion_date>
  <primary_completion_date type="Actual">April 11, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>tissue inflammation after injection of hyaluronic acid filler</measure>
    <time_frame>3 weeks to 4 months after injection</time_frame>
    <description>Presence of lymphocytes and/ or histiocytes around the filler through histologic examination [Yes/No]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>tissue response after injection of hyaluronic acid filler</measure>
    <time_frame>1 week after injection</time_frame>
    <description>Presence of lymphocytes and/ or histiocytes and/ or macrophages around the filler through histologic examination [Yes/No]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tissue response after injection and remodelling of hyaluronic acid filler</measure>
    <time_frame>3 weeks to 4 months after injection</time_frame>
    <description>Presence of lymphocytes and/ or histiocytes and/ or macrophages around the filler through histologic examination [Yes/No]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tissue response after injection and remodelling of hyaluronic acid filler</measure>
    <time_frame>1 week after injection</time_frame>
    <description>Presence of lymphocytes and/ or histiocytes and/ or macrophages around the filler through histologic examination [Yes/No]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>filler distribution in tissue</measure>
    <time_frame>3 weeks to 4 months after injection</time_frame>
    <description>The height and width of the total filler spread [mm]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>filler distribution in tissue</measure>
    <time_frame>1 week after injection</time_frame>
    <description>The height and width of the total filler spread [mm]</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Atrophy</condition>
  <arm_group>
    <arm_group_label>Hyaluronic Acid filler 1 for deep injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection Session 1 of Hyaluronic Acid filler 1, 3 weeks to 4 months before the surgery
Injection Session 2 of Hyaluronic Acid filler 1, 5 to 9 days before the surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyaluronic Acid filler 2 for deep injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Injection Session 1 of Hyaluronic Acid filler 2, 3 weeks to 4 months before the surgery
Injection Session 2 of Hyaluronic Acid filler 2, 5 to 9 days before the surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hyaluronic Acid filler</intervention_name>
    <description>Linear retrograde, subcutaneous injection of 0,5 ml of hyaluronic acid gel in one side of the abdomen or one breast, 3 weeks to 4 months before the surgery.</description>
    <arm_group_label>Hyaluronic Acid filler 1 for deep injection</arm_group_label>
    <arm_group_label>Hyaluronic Acid filler 2 for deep injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hyaluronic Acid filler</intervention_name>
    <description>Linear retrograde, subcutaneous injection of 0,5 ml of hyaluronic acid gel in other side of the abdomen or other breast, 5 to 9 days before the surgery.</description>
    <arm_group_label>Hyaluronic Acid filler 1 for deep injection</arm_group_label>
    <arm_group_label>Hyaluronic Acid filler 2 for deep injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients eligible for and requesting abdominoplasty

          -  patients eligible for and requesting bilateral breast reduction

        Exclusion Criteria:

          -  Patients prone to hypertrophic scarring or keloids

          -  Hypersensitivity to hyaluronic acid

          -  Hypersensitivity to lidocaine or amide type local anaesthetics

          -  Autoimmune disease

          -  Severe, multiple allergies or anaphylactic shock

          -  Epilepsy

          -  Heart rhythm disorders

          -  Porphyria, congenital methemoglobinemia, glucose-6 phosphate dehydrogenase
             deficiencies, treatment with methaemoglobin-inducing substances.

          -  Previous streptococcal disease (acute rheumatic fever whether or not with heart valve
             involvement)

          -  Patients on medication which slows hepatic metabolism (such as cimetidine,
             beta-blockers)

          -  Diabetes requiring insulin treatment

          -  Major system disease.

          -  Coagulation disorders. Anticoagulation therapy. Chronic use of acetylsalicylic acid.

          -  Previous surgery in the areas eligible for injections.

          -  All contraindications to their surgical treatment (such as pregnancy or lactation).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joan H Vandeputte, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>A.Z Oudenaarde (Oudenaarde General Hospital)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Brussel</name>
      <address>
        <city>Brussel</city>
        <zip>B-1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.Z. Oudenaarde</name>
      <address>
        <city>Oudenaarde</city>
        <zip>B-9700</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Flynn TC, Sarazin D, Bezzola A, Terrani C, Micheels P. Comparative histology of intradermal implantation of mono and biphasic hyaluronic acid fillers. Dermatol Surg. 2011 May;37(5):637-43. doi: 10.1111/j.1524-4725.2010.01852.x. Epub 2011 Jan 27.</citation>
    <PMID>21272119</PMID>
  </reference>
  <reference>
    <citation>Hirsch RJ, Narurkar V, Carruthers J. Management of injected hyaluronic acid induced Tyndall effects. Lasers Surg Med. 2006 Mar;38(3):202-4.</citation>
    <PMID>16485276</PMID>
  </reference>
  <reference>
    <citation>Arlette JP, Trotter MJ. Anatomic location of hyaluronic acid filler material injected into nasolabial fold: a histologic study. Dermatol Surg. 2008 Jun;34 Suppl 1:S56-62; discussion S62-3. doi: 10.1111/j.1524-4725.2008.34244.x.</citation>
    <PMID>18547183</PMID>
  </reference>
  <reference>
    <citation>Micheels P, Sarazin D, Besse S, Sundaram H, Flynn TC. A blanching technique for intradermal injection of the hyaluronic acid Belotero. Plast Reconstr Surg. 2013 Oct;132(4 Suppl 2):59S-68S. doi: 10.1097/PRS.0b013e31829a02fb.</citation>
    <PMID>24077012</PMID>
  </reference>
  <reference>
    <citation>Fran√ßa Wanick FB, Almeida Issa MC, Luiz RR, Soares Filho PJ, Olej B. Skin Remodeling Using Hyaluronic Acid Filler Injections in Photo-Aged Faces. Dermatol Surg. 2016 Mar;42(3):352-9. doi: 10.1097/DSS.0000000000000659.</citation>
    <PMID>26918965</PMID>
  </reference>
  <reference>
    <citation>Shaw RB Jr, Katzel EB, Koltz PF, Kahn DM, Girotto JA, Langstein HN. Aging of the mandible and its aesthetic implications. Plast Reconstr Surg. 2010 Jan;125(1):332-42. doi: 10.1097/PRS.0b013e3181c2a685.</citation>
    <PMID>20048624</PMID>
  </reference>
  <reference>
    <citation>Rohrich RJ, Pessa JE. The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg. 2007 Jun;119(7):2219-27; discussion 2228-31.</citation>
    <PMID>17519724</PMID>
  </reference>
  <reference>
    <citation>Pilsl U, Rosmarin W, Anderhuber F. The premaxillary space: a location for filler injection? Dermatol Surg. 2014 Mar;40(3):301-4. doi: 10.1111/dsu.12431. Epub 2014 Jan 30.</citation>
    <PMID>24479675</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 27, 2016</study_first_submitted>
  <study_first_submitted_qc>August 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2016</study_first_posted>
  <last_update_submitted>April 18, 2018</last_update_submitted>
  <last_update_submitted_qc>April 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hyaluronic Acid</keyword>
  <keyword>histology</keyword>
  <keyword>ultrasound</keyword>
  <keyword>subcutaneous</keyword>
  <keyword>adipose tissue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>pilot study on 5 patients: min, max, average measurements will be published</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

